1 Neuroepidemiology Section, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD.
2 Pacific Health Research Institute, Honolulu, HI.
Received for publication July 10, 2003; accepted for publication December 4, 2003.
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Alzheimer disease; antioxidants; dementia; diet; dietary supplements
Abbreviations: Abbreviations: APOE, apolipoprotein E; CI, confidence interval; HAAS, Honolulu-Asia Aging Study.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Two prospective studies previously reported a protective effect of dietary intake of antioxidants against Alzheimers disease (13, 14), but neither study found the same benefits in supplement users (18). Most studies evaluating the relation between dietary antioxidants and cognitive function have considered late-life diet, either in cross-sectional studies (5, 12) or in prospective studies (6, 8, 10, 13, 14) or clinical trials (17, 19) with relatively short follow-up periods. However, dementia has a long latency period, and preclinical cognitively impaired persons have reduced dietary intakes in comparison with nondemented people (20). There is evidence that measurement of specific risk factors in midlife better predicts late-life cognitive impairment, because the measures are less influenced by preclinical disease (21). Thus, it is of interest to study the association between dementia and dietary patterns measured in midlife.
The Honolulu-Asia Aging Study (HAAS) is a longitudinal study of elderly Japanese-American men in which extensive evaluations of health characteristics, including a dietary assessment, were carried out during midlife. Previously, we reported no association between dementia and antioxidant supplement intake measured within a 6-year follow-up period (15). Here we examine the association between midlife dietary intake of antioxidants and the incidence of late-life dementia and its subtypes.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
As a continuation of the Honolulu Heart Program, the HAAS was established in 1991 to study neurodegenerative diseases (23). Of the initial Honolulu Heart Program cohort, 3,734 subjects (80 percent of those eligible) ranging in age from 71 to 93 years agreed to participate in the HAAS (19911993; examination 4). Subjects were reexamined twice for dementia after the HAAS baseline assessment in 19941996 (examination 5) and 19971999 (examination 6).
The Kuakini Medical Center Institutional Review Board reviewed and approved this study. All subjects, or their caretakers if subjects were demented, provided written informed consent.
Dementia assessment
At baseline and at follow-up, subjects were first screened for dementia using the 100-point Cognitive Abilities Screening Instrument, a combination of the Hasegawa Dementia Screening Scale, the Folstein Mini-Mental State examination, and the Modified Mini-Mental State Test (24). Case-finding at examination 4 was conducted according to a multistep procedure using the Cognitive Abilities Screening Instrument score to determine subgroups for evaluation, a process described in detail elsewhere (22, 25). The dementia evaluation included a neurologic examination, neuropsychological testing, and an informant interview about changes in cognitive function and behavior. In subjects with dementia, a brain image was made and routine blood tests were conducted. On the basis of these data, a consensus diagnosis for dementia was given by the study neurologist and two physicians with expertise in dementia, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (26). Probable or possible Alzheimers disease was diagnosed according to the National Institute of Neurological and Communicative Disorders and StrokeAlzheimers Disease and Related Disorders Association criteria (27). Vascular dementia was diagnosed using the criteria of the California Alzheimers Disease Diagnostic and Treatment Centers (28). Other dementias included those due to chronic alcohol abuse, brain tumor, subdural hematoma, Parkinsons disease, Lewy body disease, Picks disease, trauma, vitamin B12 deficiency, hypothyroidism, progressive supranuclear palsy, and unknown causes.
Dietary assessment
A 24-hour dietary recall was administered to all subjects as part of examination 1 (19651968). This method is especially useful for estimating intakes in culturally diverse populations with a wide range of foods and eating habits (29). Dietitians trained in standardized procedures used appropriate food models and serving utensils to establish food consumption (30). According to predefined rules, the dietitians tallied foods eaten during the previous 24 hours on a precoded interview form (31). Subjects were asked whether the 24-hour recall was fairly typical or unusual (i.e., major difference due to under- or overeating or drinking). In addition, questions related to the frequencies of consumption of 26 selected food and drink items characteristic of Western or traditional Japanese diets, including tea, were asked at examinations 1 and 3. In 1996, the nutritional information (beta-carotene, vitamin C, vitamin E, and total energy intake) from the 24-hour recall was recoded and estimated for subjects with a typical diet (93.6 percent) using a modified Nutritionist IV (version 3.0) software program (N-Squared Computing, Salem, Oregon) that included over 9,700 food items with 75 nutrients. Nutrient estimates were calculated using the US Department of Agriculture nutrition data bank (32), the Canadian nutrition data bank (33), the Composition of Malaysian Foods (34), and other available recipe and cookbook files (Dr. Kamal Masaki, Pacific Health Research Institute (Honolulu, Hawaii), personal communication, 2002). Food items specific to Hawaii and to the Japanese population were added directly from data provided by the Cancer Research Center of Hawaii and the Standard Tables of Food Composition in Japan (35) or were based on the recipes provided by the US Department of Agriculture Recipe File or Hawaiian cookbooks created using the software. Important sources of antioxidants in the Hawaiian diet include sweet potato, taro, bok choy, konbu, nori, and wakame for beta-carotene; breadfruit, sweet potato, turnip, guava, lychee, mango, and pineapple for vitamin C; and macadamia nuts, sweet potato, and mango for vitamin E.
Flavonoid intake was estimated using mean intake of tea (green and black) at examinations 1 and 3 and the average content of flavonoids from 11 types of tea infusions as published by Hertog et al. (36). Information on wine drinking by type (red or white) was not available, but this is presumed to be a minor source of flavonoids in this population. Tea intake has been reported to be one of the main sources of flavonoids in the diet (37).
Covariates and potential confounders
We considered covariates and potential confounders that were assessed during midlife from 1965 through 1974. Variables measured at examination 1 included age, years of education, body mass index, total energy intake, physical activity, blood pressure, and cholesterol concentration. Systolic and diastolic blood pressure values corresponded to the mean of three measurements made on the left arm while the subject was seated. Serum total cholesterol was measured in previously frozen blood specimens collected from subjects in a nonfasting state using Auto-Analyzer methods (38). An index of physical activity was calculated by summing the products of five levels of habitual activity in a day by corresponding intensity factor (39). Cholesterol and physical activity index were categorized into tertiles.
Variables for other characteristics, including midlife cigarette smoking and alcohol consumption, were based on information collected from examinations 13. Cigarette smoking status was categorized as never smoker, past smoker, and current smoker; alcohol intake was categorized as no alcohol, <15 g/day, 1530 g/day, and 30 g/day. Supplemental vitamin intake (yes/no) corresponded to either intake of vitamins A, C, and E, as listed in the mailed questionnaire, or intake at examination 4. History of cardiovascular disease, including coronary heart disease and stroke events, was derived by continuous surveillance of hospital discharge and death records on Oahu from 1965 through 1997. Events were categorized relative to examination 4, as no event prior to examination 4 and no event after examination 4. Apolipoprotein E (APOE) genotyping was obtained by standard DNA amplification and restriction isotyping (40). Because few subjects were homozygous for the e4 allele, all carriers of APOE e4 were combined, and the variable was coded as a binary variable (presence/absence of APOE e4). Con-founding factors with less than 5 percent missing values had missing values replaced with dummy variables, when variables were discrete, or were given the mean value of the distribution of the study population when continuous.
Study population
Of the 3,734 men in the HAAS at baseline, 226 were demented and were excluded from subsequent analyses. Of the remaining subjects, 1,049 could not be included because of either atypical diet (n = 226, 6.4 percent), death between examination 4 and examination 5 (n = 516, 14.7 percent), or nonresponse to examination 5 (n = 307, 8.8 percent); this left 2,459 subjects for analysis. Compared with subjects from the study sample, those with an atypical diet were similar in terms of age, education, and body mass index at examination 1 and intake of supplemental vitamins. Those who died between examinations 4 and 5 (mean age at death = 83.2 years) were, at examination 1, on average older (55.3 years vs. 52.4 years; p < 0.05) and less educated (9.9 years vs. 10.8 years; p < 0.001), had a lower energy intake (2,254 kcal/day vs. 2,307 kcal/day; p < 0.05), and comprised fewer supplement users (48 percent vs. 57 percent; p < 0.001). Nonresponders to examination 5 were also older at examination 1 (52.9 years vs. 52.4 years; p < 0.01), had lower intakes of beta-carotene (423 µg/day vs. 480 µg/day; p < 0.05) and vitamin C (108 mg/day vs. 119 mg/day; p < 0.05), and comprised fewer supplement users (50 percent vs. 57 percent; p < 0.05).
Statistical analysis
Over 30.2 years of follow-up (range, 25.733.0 years), 2,224 subjects remained cognitively normal and 235 developed dementia; this included 102 cases of Alzheimers disease, 38 cases of Alzheimers disease with contributing cerebrovascular disease, 44 cases of vascular dementia, and 51 cases due to other causes. Comparisons between incident dementia cases and the nondemented were conducted using Kruskal-Wallis tests for continuous variables and chi-squared tests for categorical variables, after adjustment for age and education. Associations between intakes of specific antioxidants and outcomes were assessed after adjustment for total energy intake using the residual method (41). Intakes of antioxidants were log-transformed to normalize their distribution. Quartiles of energy-adjusted antioxidant intakes, based on their distribution in the study sample, were used to estimate the risks in the second, third, and fourth quartiles relative to the first (low intake). A combined antioxidant index was also created by summing z scores of energy-adjusted values of beta-carotene, vitamins C and E, and flavonoids, after verifying that associations between antioxidants and dementia were linear. This procedure assigns the same weight to every antioxidant and does not account for any potential prooxidant activity that could result from the interaction among antioxidants. Values of specific log-transformed antioxidant z scores ranged from 12.0 to 2.4, with 0 as the mean and 1 as the standard deviation, negative values indicating lower intakes of antioxidants. Values of the combined antioxidant index ranged from 17.7 to 5.1, with 0 as the mean and 2.2 as the standard deviation. Z-score sums were coded into three categories using ±1.5 as the cutoff point. Subjects with a high intake comprised 22.2 percent of the group; subjects with a low intake comprised 19.6 percent and constituted the reference group.
Cox proportional hazards regression with delayed entry and age as the time scale was used to identify and adjust for confounding variables (42). The age of onset was assigned at the midpoint of the interval between the last examination without dementia and the first follow-up examination with dementia. Subjects who died or did not participate in subsequent follow-up examinations were censored as of the time of their last evaluation. The proportional hazards assumptions were tested graphically and by including the interaction of time with covariates. In addition to age and education, associations between specific antioxidants and different outcomes were adjusted for smoking status, alcohol intake, body mass index, physical activity, total energy intake, year of birth (coded in tertiles), cholesterol concentration, systolic and diastolic blood pressures, history of cardiovascular disease, supplemental vitamin intake, and APOE e4. Effect modification of risk of dementia by smoking habits, body mass index, total energy intake, and APOE e4 was investigated in stratified analysis. Analyses were performed using SAS software, version 6.12 (SAS Institute, Inc., Cary, North Carolina).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
These findings contribute uniquely to the body of prospectively collected data on antioxidants and the risk of dementia. Our results are based on a large community-based sample of elderly Japanese-American men that has been followed extensively for research purposes for more than 30 years. Dietary intake was estimated during midlife, which makes it less likely that eating behavior was altered by preclinical changes related to dementia. Furthermore, the exposure of several potential confounders involving dietary patterns and cognitive function was documented throughout midlife, up to the end of the follow-up period.
Limitations of these analyses must be recognized. Of all eligible subjects, 29.9 percent could not be included in the study sample because they either died or did not participate in the first follow-up. Distributions of antioxidants across quartiles of intake were not different between deceased or nonresponding subjects and subjects included in the analyses. However, we cannot exclude the possibility that persons not included in the analysis had a higher risk of dementia than those who were included.
Our results are also limited because nutrient intakes were determined from a single 24-hour dietary recall that may not be representative of usual food selection. In this study, dietary information was assessed by skilled dietitians who used several quantity estimation tools. Only subjects with recalls typical of their usual diet were considered. Because of subjects relatively young age at examination 1, the time period for which they were questioned (the preceding 24 hours), and the use of skilled interviewers, the accuracy of data on dietary intake should have been high (43). Furthermore, the existence of midlife long-term eating patterns has been demonstrated in this population by the reproducibility of dietary frequency data over a 6-year period (between examination 1 and examination 3) (30). Finally, considering the large sample size of our study population, a single day of recall may have been adequate for determination of the average intake of antioxidants (43).
Previous prospective analyses have yielded inconsistent results. Dietary assessments were collected closer in time to the onset of dementia, and not all studies were corrected for important confounding factors. In the Rotterdam Study (13), wherein dietary intake was estimated with a semiquantitative food frequency questionnaire in subjects aged 68 years, on average, high intake of vitamins C and E was found to be associated with lower risks of Alzheimers disease after 6 years of follow-up. A suggestion of a protective effect of vitamin E against Alzheimers disease was also reported in the Chicago Health and Aging Project after 3.9 years of follow-up (14). However, these latter results were based on dietary data collected with a self-administered food frequency questionnaire 2.3 years before the dementia assessment in subjects aged 73 years, on average. In contrast, total intake of vitamins C and E was not associated with the risk of Alzheimers disease in the Washington Heights-Inwood Columbia Aging Project after 4.0 years of follow-up (16). In that study, dietary data were measured using a semiquantitative food frequency questionnaire administered between baseline and the first annual follow-up visit by telephone in subjects aged 75 years, on average. As in our cohort (15), no association with use of supplemental vitamins was observed in these three studies. Finally, a protective association between flavonoid intake and dementia was found in the PAQUID Study after a 5-year follow-up period (10). Dietary data were estimated using a simple nutritional questionnaire in subjects aged 76 years, on average.
Inconsistent findings were also reported in the few trials investigating the effects of antioxidant vitamins on cognitive function and dementia. Compared with placebo, treatment with vitamin E for 2 years in 341 persons with probable Alzheimers disease of moderate severity was beneficial in slowing the progression of disease, but no improvement in cognitive test scores was noticed (17). In the MRC/BHF Heart Protection Study, which included 20,536 persons allocated to receive either antioxidant vitamin supplementation (vitamins E and C and beta-carotene) or placebo, no treatment differences were found in the percentage of persons defined as cognitively impaired or in mean cognitive scores after 5 years of treatment (19). In addition, no difference was observed in the number of persons who developed dementia during follow-up.
In this study, we did not observe any protective effect from midlife intakes of beta-carotene, vitamin C, and flavonoids against dementia and its subtypes. Even though higher vitamin E intake appeared to increase the risk of dementia, particularly Alzheimers disease with and without contributing cerebrovascular disease, these associations were inconsistent across quartiles of intakes or were of marginal statistical significance. The significant finding of an increased risk of dementia with the combined antioxidant index may be more difficult to interpret, because this index was computed using all four antioxidants and assigning them the same weight. A possible explanation for this phenomenon could be the antioxidant paradox, which says that when antioxidants interact with one another they become prooxidants (44). According to this concept, a diet too high in antioxidants would favor oxidative stress. However, the fact that we did not observe any association between high supplement intakes of vitamins C and E and the incidence of dementia and subtypes does not support this argument (15). This discrepancy could also be attributed to chance.
In summary, no association was found in this study between midlife dietary intakes of beta-carotene, vitamin C, and flavonoids and the risk of late-onset dementia and its subtypes. The relation between vitamin E and risk of dementia needs further investigation.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
NOTES |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|